Share Prices & Company Research


15 May 2017

Mark tackles 100km Cotswold Challenge for Cancer Research UK

It was challenging enough the first time Mark Rigby undertook a fundraising 100km journey, when he walked from London to Cambridge - but one year later, he is preparing to do it all over again.

Mark, manager of the Cambridge branch of investment management and stockbroking firm Redmayne-Bentley, is planning to tackle the 100km Cotswold Way from Bath to Cheltenham for Cancer Research UK in July in memory of his mother, Patricia Lowe, who passed away in 2011.

He said: “I just hope to make a contribution, however small, towards the fight against cancer, which is my main motivation for raising this money.”

He will trek through rolling hills, mud tracks and woodland with his brothers, Luke and Neil, along with three of their friends, on 1st and 2nd July. All six are raising money for cancer-related charities.

Mark, who raised more than £1,400 for Macmillan Cancer Support through his journey last year, added: “I actually do enjoy the walk as well! I thought the first walk would be absolute torture and it really was hard work, but I was happy to do it again.”

Every year Cancer Research UK spends hundreds of millions of pounds on research into diagnosing, preventing and treating cancer. The organisation is the biggest single independent funder of cancer research in Europe, supporting the work of more than 4,000 scientists, doctors and nurses across the UK.

If you would like to sponsor Mark, please visit his Just Giving page at

Notes to the Editor

Established in 1875, Redmayne-Bentley is one the UK’s largest independently owned investment management and private client stockbroking firms, with 37 regional offices throughout the UK and in the Republic of Ireland.

Redmayne-Bentley has experienced commentators available for comment on personal finance and stock market issues. 

Mark tackles 100km Cotswold Challenge for Cancer Research UK
We offer complimentary investment publications produced by our in-house Investment Research team. Please click here to view our range.